| Title | Authors | Date | PubMed ID |
|---|
| Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. | Ensor CM, Tai HH | 1994 Sep 21 | 8086429 |
| NAD+-dependent 15-hgydroxyprostaglandin dehydrogenase from porcine kidney. II. Kinetic studies. | Kung-Chao DT, Tai HH | 1980 Jul 10 | 7190439 |
| 15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids. | Wendell SG, Golin-Bisello F, Wenzel S, Sobol RW, Holguin F, Freeman BA | 2015 Feb 27 | 25586183 |
| Kinetic studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. | Jarabak J, Braithwaite SS | 1976 Nov | 187123 |
| [15-Hydroxyprostaglandin dehydrogenase from human placenta, II. Steady state kinetics and influence of prostaglandin F2alpha analogues (author's transl)]. | Rückrich MF, Wendel A, Schlegel W, Jackisch R, Jung A | 1975 Jun | 171213 |
| Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2. | Cho H, Huang L, Hamza A, Gao D, Zhan CG, Tai HH | 2006 Oct 1 | 16828555 |
| NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. | Tai HH, Cho H, Tong M, Ding Y | 2006 | 16533162 |
| Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation. | Hamza A, Cho H, Tai HH, Zhan CG | 2005 Jul 15 | 15908215 |
| Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase. | Clish CB, Sun YP, Serhan CN | 2001 Nov 9 | 11688989 |
